Lipids & Statins · Note 05
Stopping statins after 70 may be safer than expected, but there's a catch
A study of nearly 1,900 older adults suggests stopping statins after 70 may be relatively safe in the short term for people without prior heart attack or stroke, but longer follow-up shows more serious events.
Statins are among the most widely prescribed medicines in the world, and a large share of users are over 70. For people who have never had a heart attack or stroke, the balance of benefit and burden in later life is genuinely uncertain, which is why discontinuation is studied rather than assumed.
The study followed nearly 1,900 older adults who stopped statin therapy. In the short term, the strategy looked relatively safe for people without established cardiovascular disease. Over longer follow-up, however, serious cardiovascular events and death were more frequent, suggesting that the protection does not disappear simply because a patient is older.
The practical lesson is not that everyone should stay on a statin forever. It is that stopping is a decision with consequences, and it should be made with a clinician who can weigh life expectancy, comorbidity, side effects and patient goals. The source report should be read for the exact follow-up periods.
Keep in mind
- Longer follow-up showed more serious cardiovascular events and death.
- Stopping remains an individual decision, not a default.
Source and reuse
This is an independent editorial summary written for Heartline. It is not a verbatim reproduction and does not reproduce paywalled text. Reporting, data and quotations belong to ScienceDaily Heart Disease. Read the original at the link provided.
Metadata basis: the publisher’s public RSS feed and the abstract it exposes. Where the full article could not be accessed, this note is explicitly metadata-based and limited to what the feed disclosed. It is not medical advice.
Read the original at ScienceDaily Heart Disease →